LI Hongli, YAN Huili. Relationships of glucose metabolism with sex hormones and endometrial receptivity in patients with polycystic ovary syndrome at childbearing age[J]. Journal of Clinical Medicine in Practice, 2024, 28(10): 106-111. DOI: 10.7619/jcmp.20233856
Citation: LI Hongli, YAN Huili. Relationships of glucose metabolism with sex hormones and endometrial receptivity in patients with polycystic ovary syndrome at childbearing age[J]. Journal of Clinical Medicine in Practice, 2024, 28(10): 106-111. DOI: 10.7619/jcmp.20233856

Relationships of glucose metabolism with sex hormones and endometrial receptivity in patients with polycystic ovary syndrome at childbearing age

More Information
  • Received Date: November 29, 2023
  • Revised Date: March 11, 2024
  • Available Online: May 31, 2024
  • Objective 

    To investigate the relationships of glucose metabolism with sex hormones and endometrial receptivity in patients with polycystic ovary syndrome (PCOS) at childbearing age.

    Methods 

    Glucose metabolism indexes, sex hormone indexes and endometrial receptivity related indexes were detected in 90 PCOS patients (study group) at childbearing age and 90 healthy people (control group) at childbearing age. According to condition of endometrial receptivity, the PCOS patients were divided into poor receptivity group (n=28) and good receptivity group (n=62), and the influencing factors of endometrial receptivity in PCOS patients were analyzed. Pearson method was used to analyze the relationships of glucose metabolism indexes with sex hormone indexes and endometrial receptivity related indexes.

    Results 

    In the study group, body mass index (BMI), fasting plasma glucose (FPG), fasting insulin (FINS), homeostasis model assessment of insulin resistance (HOMA-IR), luteinizing hormone (LH), testosterone (T), progesterone (P), estradiol (E2), pulsatility index (PI) and resistance index (RI) of endometrial spiral artery were significantly higher than those in the control group (P < 0.05); the endometrial thickness of the study group was significantly lower than that of the control group (P < 0.05). Multivariate Logistic regression analysis revealed that T (OR=2.593), FINS (OR=2.898), HOMA-IR (OR=3.277), P (OR=4.362), E2 (OR=2.392) and endometrial thickness (OR=0.485) were the factors of poor endometrial receptivity in patients with PCOS (P < 0.05). FINS and HOMA-IR showed significant positive correlations with LH, T as well as PI and RI of the endometrial spiral artery (P < 0.05), and a significant negative correlation with endometrial thickness (P < 0.05).

    Conclusion 

    PCOS patients have glucose metabolism and sex hormones disorders as well as impaired endometrial receptivity, and FINS and HOMA-IR are closely related to sex hormones and endometrial receptivity related indicators.

  • [1]
    ALESI S, EE C, MORAN L J, et al. Nutritional supplements and complementary therapies in polycystic ovary syndrome[J]. Adv Nutr, 2022, 13(4): 1243-1266. doi: 10.1093/advances/nmab141
    [2]
    KIM J H, KIM O, JUNG H, et al. Body mass index, menstruation, acne, and hirsutism of polycystic ovary syndrome in women: a cross-sectional study[J]. Health Care Women Int, 2022, 43(1/2/3): 85-97.
    [3]
    DAMBALA K, PASCHOU S A, MICHOPOULOS A, et al. Biomarkers of endothelial dysfunction in women with polycystic ovary syndrome[J]. Angiology, 2019, 70(9): 797-801. doi: 10.1177/0003319719840091
    [4]
    ZHONG P W, GUAN B X, LIN Y T, et al. Changes in inflammatory factors, oxidative stress, glucose and lipid metabolism, and insulin resistance in patients with polycystic ovary syndrome[J]. Cell Mol Biol, 2022, 67(5): 45-50. doi: 10.14715/cmb/2021.67.5.6
    [5]
    贾涔琳, 张治芬, 金雪静, 等. 高雄激素型多囊卵巢综合征与糖脂代谢及甲状腺功能的关系[J]. 浙江医学, 2020, 42(13): 1404-1408. https://www.cnki.com.cn/Article/CJFDTOTAL-ZJYE202013017.htm
    [6]
    GUO F, HUANG Y F, FERNANDO T, et al. Altered molecular pathways and biomarkers of endometrial receptivity in infertile women with polycystic ovary syndrome[J]. Reprod Sci, 2022, 29(12): 3335-3345. doi: 10.1007/s43032-022-00845-x
    [7]
    HERNÁNDEZ-JIMÉNEZ J L, BARRERA D, ESPINOZA-SIMÓN E, et al. Polycystic ovarian syndrome: signs and feedback effects of hyperandrogenism and insulin resistance[J]. Gynecol Endocrinol, 2022, 38(1): 2-9. doi: 10.1080/09513590.2021.2003326
    [8]
    PALOMBA S, FALBO A I, MARCI R, et al. Is endometrial receptivity impaired in women with polycystic ovary syndrome[J]. Minerva Obstet Gynecol, 2023, 75(2): 172-180.
    [9]
    翁瑞文, 刘义, 张蔚, 等. 多囊卵巢综合征患者雄激素与糖代谢指标的关系研究[J]. 中国全科医学, 2022, 25(32): 4046-4051. https://www.cnki.com.cn/Article/CJFDTOTAL-QKYX202232012.htm
    [10]
    胡扬喜, 刘岩, 李梦竹, 等. 腹腔镜下袖状胃切除术对肥胖型多囊卵巢综合征的疗效分析[J]. 实用临床医药杂志, 2024, 28(7): 49-52. doi: 10.7619/jcmp.20234176?viewType=HTML
    [11]
    宋颖, 李蓉. 多囊卵巢综合征中国诊疗指南解读[J]. 实用妇产科杂志, 2018, 34(10): 737-741. https://www.cnki.com.cn/Article/CJFDTOTAL-SFCZ201810010.htm
    [12]
    张丽欣, 张春晓. PCOS不孕症患者子宫内膜组织miR-21、miR-155表达及其与内膜容受性的关系[J]. 生殖医学杂志, 2022, 8(11): 1528-1533. https://www.cnki.com.cn/Article/CJFDTOTAL-SZYX202211009.htm
    [13]
    ROSTAMTABAR M, ESMAEILZADEH S, TOURANI M, et al. Pathophysiological roles of chronic low-grade inflammation mediators in polycystic ovary syndrome[J]. J Cell Physiol, 2021, 236(2): 824-838. doi: 10.1002/jcp.29912
    [14]
    栗凤霞, 王艳硕, 史艳想, 等. 维生素E联合二甲双胍治疗对多囊卵巢综合征不孕症患者的影响[J]. 实用临床医药杂志, 2022, 26(14): 97-100, 104. doi: 10.7619/jcmp.20220640?viewType=HTML
    [15]
    JIANG N X, LI X L. The disorders of endometrial receptivity in PCOS and its mechanisms[J]. Reprod Sci, 2022, 29(9): 2465-2476. doi: 10.1007/s43032-021-00629-9
    [16]
    邓焕丽, 张欢. 多囊卵巢综合征患者糖代谢异常影响因素分析[J]. 中国妇幼保健, 2021, 36(23): 5533-5536. https://www.cnki.com.cn/Article/CJFDTOTAL-ZFYB202123051.htm
    [17]
    梁建梅, 徐国萍, 孙素丽, 等. 血清抗苗勒管激素在多囊卵巢综合征患者中的水平及预测价值[J]. 中国妇幼保健, 2021, 36(21): 5000-5003. https://www.cnki.com.cn/Article/CJFDTOTAL-ZFYB202121036.htm
    [18]
    BANNIGIDA D M, NAYAK B S, VIJAYARAGHAVAN R. Insulin resistance and oxidative marker in women with PCOS[J]. Arch Physiol Biochem, 2020, 126(2): 183-186. doi: 10.1080/13813455.2018.1499120
    [19]
    唐子轩, 李璟, 黄琦, 等. 多囊卵巢综合征患者脂联素与游离睾酮指数及胰岛素抵抗的相关性研究[J]. 中国全科医学, 2023, 26(8): 927-932, 938. https://www.cnki.com.cn/Article/CJFDTOTAL-QKYX202308004.htm
    [20]
    赵子涵, 于潇, 刘鹏飞, 等. 多囊卵巢综合征不孕患者性激素水平与免疫失衡及胰岛素抵抗指数的关系研究[J]. 现代生物医学进展, 2022, 8(19): 3680-3683, 3693. https://www.cnki.com.cn/Article/CJFDTOTAL-SWCX202219015.htm
    [21]
    高金艳, 姚红佳. 多囊卵巢综合征患者性激素水平与胰岛素抵抗的相关性分析[J]. 中国妇幼保健, 2019, 34(4): 766-768. https://www.cnki.com.cn/Article/CJFDTOTAL-ZFYB201904014.htm
    [22]
    WANG C, WEN Y X, MAI Q Y. Impact of metabolic disorders on endometrial receptivity in patients with polycystic ovary syndrome[J]. Exp Ther Med, 2022, 23(3): 221. doi: 10.3892/etm.2022.11145
  • Related Articles

    [1]CHENG Baoxiang, CAO Lei. Expression characteristics of serum homocysteine and hypersensitive C reactive protein in patients with coronary atherosclerotic heart disease and clinical significance[J]. Journal of Clinical Medicine in Practice, 2020, 24(6): 94-97. DOI: 10.7619/jcmp.202006026
    [2]BAI Yun, ZHU Hongyan, WANG Haifeng. Expression of high-sensitivity C reactive protein, serum cystatin C in patients with type 2 diabetes mellitus and its correlation with degree of vascular lesions[J]. Journal of Clinical Medicine in Practice, 2018, (21): 52-54. DOI: 10.7619/jcmp.201821016
    [3]ZHONG Xiaoling, ZHANG Jing, LI Ping. Application of combined detection of Cys-C, hs-CRP,U-mAlb and urine β2-MG in early diagnosis of patients with diabetic nephropathy[J]. Journal of Clinical Medicine in Practice, 2015, (13): 5-7,11. DOI: 10.7619/jcmp.201513002
    [4]WANG Junjun, YU Chunjuan, DING Qilong, XING Ting. Correlation between serum high sensitivity C-reactive protein and atherosclerosis in patients with type 2 diabetes mellitus[J]. Journal of Clinical Medicine in Practice, 2015, (5): 5-7. DOI: 10.7619/jcmp.201505002
    [5]HOU Fenghui, DUAN Lizhi, YU Li, WU Huimin. Expression of serum lipoprotein and high sensitivity C-reactive protein in serum of patients with type 2 diabetic nephropathy and its clinical significance[J]. Journal of Clinical Medicine in Practice, 2014, (17): 33-35. DOI: 10.7619/jcmp.201417010
    [6]ZHOU Hualan, HU Youdong, GUO Dianxuan, LI Xia, XU Peijing. Relationship between adiponectin,B-type natriuretic peptide,high sensitivity C-reactive protein and cardiac function classification in patients with degenerative heart valvular disease[J]. Journal of Clinical Medicine in Practice, 2014, (16): 25-27. DOI: 10.7619/jcmp.201416007
    [7]HUANG Shaomin. Feasibility analysis of hypersensitive c-reactive protein and blood lipid of joint detection in the diagnosis of heart cerebrovascular disease[J]. Journal of Clinical Medicine in Practice, 2013, (16): 82-83,89. DOI: 10.7619/jcmp.201316031
    [8]YANG Jiqing, CHEN Liyan, DAI Wan'an, XU Xianzao, LIAO Mingfeng, LI Zongqing. Detection value of serum pentraxin-3,hypersensitive C-reactive protein and gamma-glutamyl transpeptidase in patients with type 2 diabetes mellitus[J]. Journal of Clinical Medicine in Practice, 2013, (7): 124-125,132. DOI: 10.7619/jcmp.201307045
    [9]ZHANG Ya-ting. Clinical significance of serum high sensitivity C- reactive protein and serum lipids in patients with type 2 diabetes mellitus[J]. Journal of Clinical Medicine in Practice, 2012, (11): 119-120. DOI: 10.3969/j.issn.1672-2353.2012.11.040
    [10]ZHANG Jin-chen. Effect of Rosuvastatin on lipoprotein and high sensitivity C-reactive protein in cerebral infarction patients[J]. Journal of Clinical Medicine in Practice, 2011, (11): 93-94,96. DOI: 10.3969/j.issn.1672-2353.2011.11.031
  • Cited by

    Periodical cited type(4)

    1. 陈慧,班锦青,梁静林. 不同送鞘方式在改良赛丁格PICC技术中的应用研究进展. 微创医学. 2024(02): 187-190 .
    2. 陈静,丁菊香. 莫匹罗星软膏联合新癀片贴敷应用于化疗药物皮下注射所致皮肤损害的临床研究. 生命科学仪器. 2024(03): 50-52 .
    3. 阳艳晖,肖少文,梁桂兴. 专科护理门诊实施责任制整体护理对留置PICC导管相关性皮肤损伤患者的影响. 中外医疗. 2024(27): 156-159+176 .
    4. 陈金莲,蔡燕萍. 改良型中等长度导管在晚期恶性肿瘤患者中的应用效果. 中国医药指南. 2023(34): 81-84 .

    Other cited types(0)

Catalog

    Article views (101) PDF downloads (3) Cited by(4)

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return